X-18642022-GC-CT
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000330.4(RS1):c.656_657delGCinsAG(p.Cys219*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 23)
Consequence
RS1
NM_000330.4 stop_gained
NM_000330.4 stop_gained
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.57
Genes affected
RS1 (HGNC:10457): (retinoschisin 1) This gene encodes an extracellular protein that plays a crucial role in the cellular organization of the retina. The encoded protein is assembled and secreted from photoreceptors and bipolar cells as a homo-oligomeric protein complex. Mutations in this gene are responsible for X-linked retinoschisis, a common, early-onset macular degeneration in males that results in a splitting of the inner layers of the retina and severe loss in vision. [provided by RefSeq, Oct 2008]
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-18642022-GC-CT is Pathogenic according to our data. Variant chrX-18642022-GC-CT is described in ClinVar as [Pathogenic]. Clinvar id is 2123578.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RS1 | NM_000330.4 | c.656_657delGCinsAG | p.Cys219* | stop_gained | ENST00000379984.4 | NP_000321.1 | ||
RS1 | XM_047442337.1 | c.560_561delGCinsAG | p.Cys187* | stop_gained | XP_047298293.1 | |||
CDKL5 | NM_001037343.2 | c.2714-3985_2714-3984delGCinsCT | intron_variant | NP_001032420.1 | ||||
CDKL5 | NM_003159.3 | c.2714-3985_2714-3984delGCinsCT | intron_variant | NP_003150.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RS1 | ENST00000379984.4 | c.656_657delGCinsAG | p.Cys219* | stop_gained | 1 | NM_000330.4 | ENSP00000369320.3 | |||
CDKL5 | ENST00000379989.6 | c.2714-3985_2714-3984delGCinsCT | intron_variant | 1 | ENSP00000369325.3 | |||||
CDKL5 | ENST00000379996.7 | c.2714-3985_2714-3984delGCinsCT | intron_variant | 1 | ENSP00000369332.3 | |||||
RS1 | ENST00000476595.1 | n.1147_1148delGCinsAG | non_coding_transcript_exon_variant | 5/5 | 1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 09, 2022 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the RS1 protein in which other variant(s) (p.Cys223Tyr) have been determined to be pathogenic (PMID: 20061330, 22245991; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with RS1-related conditions. Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. This sequence change creates a premature translational stop signal (p.Cys219*) in the RS1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 6 amino acid(s) of the RS1 protein. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.